Inovio Pharmaceuticals
INO
#8887
Rank
ยฃ0.10 B
Marketcap
ยฃ1.59
Share price
-0.23%
Change (1 day)
-49.62%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -ยฃ81.66 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.18 Million. In 2024 the company made an earning of -ยฃ80.15 Million, an increase over its 2023 earnings that were of -ยฃ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ81.66 Million1.89%
2024 -ยฃ80.15 Million-20.03%
2023 -ยฃ0.11 Billion-51.56%
2022 -ยฃ0.21 Billion-8.26%
2021 -ยฃ0.23 Billion95.4%
2020 -ยฃ0.12 Billion36.62%
2019 -ยฃ84.48 Million20.19%
2018 -ยฃ70.29 Million10.94%
2017 -ยฃ63.36 Million9.59%
2016 -ยฃ57.81 Million118.9%
2015 -ยฃ26.41 Million-10.67%
2014 -ยฃ29.57 Million83.32%
2013 -ยฃ16.13 Million
2011 -ยฃ16.64 Million15.64%
2010 -ยฃ14.39 Million37.7%
2009 -ยฃ10.45 Million2.19%
2008 -ยฃ10.23 Million-14.09%
2007 -ยฃ11.9 Million19.12%
2006 -ยฃ9.99 Million9.62%
2005 -ยฃ9.12 Million5.77%
2004 -ยฃ8.62 Million73.08%
2003 -ยฃ4.98 Million12.75%
2002 -ยฃ4.42 Million
2000 -ยฃ6.69 Million53.93%
1999 -ยฃ4.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.87 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.24 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ56.19 Million-30.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.28 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ17.28 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ6.97 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
ยฃ7.39 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-ยฃ2.07 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA